603 related articles for article (PubMed ID: 10891404)
1. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
[TBL] [Abstract][Full Text] [Related]
2. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
[TBL] [Abstract][Full Text] [Related]
3. An immunodominant, cross-reactive B-cell epitope region is located at the C-terminal part of the hamster polyomavirus major capsid protein VP1.
Siray H; Frömmel C; Voronkova T; Hahn S; Arnold W; Schneider-Mergener J; Scherneck S; Ulrich R
Viral Immunol; 2000; 13(4):533-45. PubMed ID: 11192300
[TBL] [Abstract][Full Text] [Related]
4. Development of a vaccine marker technology: display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination.
Neugebauer M; Walders B; Brinkman M; Ruehland C; Schumacher T; Bertling WM; Geuther E; Reiser CO; Reichel C; Strich S; Hess J
Biotechnol J; 2006 Dec; 1(12):1435-46. PubMed ID: 17109492
[TBL] [Abstract][Full Text] [Related]
5. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
Skrastina D; Bulavaite A; Sominskaya I; Kovalevska L; Ose V; Priede D; Pumpens P; Sasnauskas K
Vaccine; 2008 Apr; 26(16):1972-81. PubMed ID: 18343539
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
[TBL] [Abstract][Full Text] [Related]
7. Yeast cells allow high-level expression and formation of polyomavirus-like particles.
Sasnauskas K; Buzaite O; Vogel F; Jandrig B; Razanskas R; Staniulis J; Scherneck S; Krüger DH; Ulrich R
Biol Chem; 1999 Mar; 380(3):381-6. PubMed ID: 10223341
[TBL] [Abstract][Full Text] [Related]
8. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
de Prat-Gay G
Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
[TBL] [Abstract][Full Text] [Related]
9. Selection from a peptide library of the antigenic determinants of a protein.
Castagnoli L; Vetriani C; Gonfloni S; Felici F; Vispo NS; Cesareni G
Year Immunol; 1993; 7():41-9. PubMed ID: 7690508
[No Abstract] [Full Text] [Related]
10. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
11. Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles.
Rueda P; Hurtado A; del Barrio M; Martínez-Torrecuadrada JL; Kamstrup S; Leclerc C; Casal JI
Virology; 1999 Oct; 263(1):89-99. PubMed ID: 10544085
[TBL] [Abstract][Full Text] [Related]
12. Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice.
Gedvilaite A; Zvirbliene A; Staniulis J; Sasnauskas K; Krüger DH; Ulrich R
Viral Immunol; 2004; 17(1):51-68. PubMed ID: 15018662
[TBL] [Abstract][Full Text] [Related]
13. A new form of particulate single and multiple immunogen delivery system based on recombinant bluetongue virus-derived tubules.
Mikhailov M; Monastyrskaya K; Bakker T; Roy P
Virology; 1996 Mar; 217(1):323-31. PubMed ID: 8599217
[TBL] [Abstract][Full Text] [Related]
14. Changing the surface of a virus shell fusion of an enzyme to polyoma VP1.
Gleiter S; Stubenrauch K; Lilie H
Protein Sci; 1999 Dec; 8(12):2562-9. PubMed ID: 10631971
[TBL] [Abstract][Full Text] [Related]
15. Homogeneous processing and presentation of a recombined T cell epitope in inbred mice of different non-MHC genetic background.
Lo-Man R; Martineau P; Hofnung M; Leclerc C
Cell Immunol; 1996 Sep; 172(2):180-91. PubMed ID: 8964079
[TBL] [Abstract][Full Text] [Related]
16. Behavior of a short preS1 epitope on the surface of hepatitis B core particles.
Borisova G; Borschukova O; Skrastina D; Dislers A; Ose V; Pumpens P; Grens E
Biol Chem; 1999 Mar; 380(3):315-24. PubMed ID: 10223334
[TBL] [Abstract][Full Text] [Related]
17. Mapping of antigenic domains in poliovirus VP1 involved in structural rearrangements during virus morphogenesis and antigenic alterations of the virion.
Ketterlinus R; Wiegers K
Virology; 1994 Oct; 204(1):27-37. PubMed ID: 7522372
[TBL] [Abstract][Full Text] [Related]
18. Chimeric parvovirus B19 capsids for the presentation of foreign epitopes.
Brown CS; Welling-Wester S; Feijlbrief M; Van Lent JW; Spaan WJ
Virology; 1994 Feb; 198(2):477-88. PubMed ID: 7507280
[TBL] [Abstract][Full Text] [Related]
19. A point mutation in VP1 of coxsackievirus B4 alters antigenicity.
Halim S; Ramsingh AI
Virology; 2000 Mar; 269(1):86-94. PubMed ID: 10725201
[TBL] [Abstract][Full Text] [Related]
20. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
